No Record Found
Sector
PharmaceuticalsOpen
₹167.09Prev. Close
₹170.5Turnover(Lac.)
₹0.85Day's High
₹167.09Day's Low
₹167.0952 Week's High
₹202.0652 Week's Low
₹69Book Value
₹38.6Face Value
₹10Mkt Cap (₹ Cr.)
395.27P/E
38.14EPS
4.47Divi. Yield
012 Aug 2025
12:00 AM
AGM
Announcement Date: 12 Aug, 2025
12 Aug 2025
12:00 AM
BookCloser
6 Nov 2025
12:00 AM
Board Meeting
Agenda : Audited Result
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 23.66 | 23.66 | 23.66 | 23.66 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 61.15 | 57.18 | 49.8 | 38.31 |
Net Worth | 84.81 | 80.84 | 73.46 | 61.97 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 85.14 | 71.21 | 42.47 | 77.2 |
yoy growth (%) | 19.54 | 67.68 | -44.98 | 18.85 |
Raw materials | -39.28 | -36.52 | -19.98 | -38.28 |
As % of sales | 46.13 | 51.28 | 47.05 | 49.58 |
Employee costs | -14.5 | -11.98 | -10.25 | -7.47 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 7.3 | 5.82 | -1.87 | -14.27 |
Depreciation | -5.49 | -4.47 | -3.26 | -3.64 |
Tax paid | 0 | 0 | 0 | -2.17 |
Working capital | -0.75 | 16.58 | 6.23 | -27.03 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 19.54 | 67.68 | -44.98 | 18.85 |
Op profit growth | 11.6 | 738.01 | -124.32 | -3.16 |
EBIT growth | 23.33 | -468.5 | -76.13 | -6.25 |
Net profit growth | -11.59 | -123.11 | 53.2 | -10.93 |
| Particulars (Rupees in Crores.) | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|---|
Gross Sales | 43.36 | 47.17 | 64.96 | 85.32 | 97.67 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 43.36 | 47.17 | 64.96 | 85.32 | 97.67 |
Other Operating Income | 0 | 0 | 0 | 0 | 41.11 |
Other Income | 1.66 | 31.33 | 1.14 | 1.98 | 4.9 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,784.1 | 91.59 | 4,28,077.35 | 564.22 | 0.9 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,454 | 68.15 | 1,71,324.13 | 696 | 0.46 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,731.4 | 59.15 | 1,26,229.4 | 597 | 0.16 | 2,707 | 249.83 |
Cipla Ltd CIPLA | 1,526.8 | 23.72 | 1,23,294.16 | 1,210.53 | 1.05 | 4,495.16 | 411.56 |
Dr Reddys Laboratories Ltd DRREDDY | 1,250.2 | 19.33 | 1,04,335.99 | 387.3 | 0.64 | 4,602.9 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
E D & Wholetime Director
Shanmugam Hemalatha
ED / WTD
Vinayak Dinesh Dendukuri
Non-Exec & Non-Independent Dir
Upendar Mekala Reddy
Chairman & Independent Directo
Ravichandran Chitra
Independent Non Exe. Director
Navin Kumar
Company Sec. & Compli. Officer
A Mohanachandran
Non Executive Director
Akilapriya Chandrashekar Raju
Independent Non Exe. Director
Palamadai Krishnan Sundaresan
Bafna Towers New No 68,
Old No 299 Thambu Chetty St,
Tamil Nadu - 600001
Tel: 91-44-25267517/25270992/4267755
Website: http://www.bafnapharma.com
Email: cs@bafnapharma.com; info@bafnapharma.com
Subramanian Building,
V Floor, 1 Club House Road,
Chennai - 600 002
Tel: 91-044-28460390 (5 L
Website: www.cameoindia.com
Email: cameo@cameoindia.com
Summary
Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing p...
Read More
Reports by Bafna Pharmaceuticals Ltd
What is the Bafna Pharmaceuticals Ltd share price today?
What is the Market Cap of Bafna Pharmaceuticals Ltd?
What is the PE and PB ratio of Bafna Pharmaceuticals Ltd?
What is the 52 Week High and Low of Bafna Pharmaceuticals Ltd?
What is the CAGR of Bafna Pharmaceuticals Ltd?
What is the shareholding pattern of Bafna Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.